[1] Barondes S H, Castronovo V, Cooper D N, et al. Galectins: a family of animal betagalactoside- binding lectins [J]. Cell, 1994, 76(4): 597-598.
[2] Papaspyridonos M, McNeill E, Bono J P D, et al. Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction[J]. Arterioscler Thromb Vasc Biol, 2008, 28(3): 433-440.
[3] Woo H J, Shaw L M, Messier J M, et al. The major non-integrin laminin binding protein of macrophages is identical to carbohydrate binding protein 35 (Mac-2) [J]. Journal of Biological
Chemistry, 1990, 265(13): 7097-7099.
[4] Ochieng J, Green B, Evans S, et al. Modulation of the biological functions of galectin-3 by matrix metalloproteinases [J]. Biochimica Et Biophysica Acta, 1998, 1379(1): 97-106.
[5] Liu F T, Patterson R J, Wang J L. Intracellular functions of galectins [J]. Biochimica Et Biophysica Acta, 2002, 1572(2/3): 263-273.
[6] Hughes R C. Secretion of the galectin family of mammalian carbohydrate-binding proteins [J]. Biochimica Et Biophysica Acta, 1999, 1473(1): 172-185.
[7] Hrdlickovacela E, Plzak J, Smetana K, et al. Detection of galectin-3 in tear fluid at disease states and immunohistochemical and lectin histochemical analysis in human corneal and
conjunctival epithelium [J]. British Journal of Ophthalmology, 2001, 85(11): 1336-1340.
[8] Cao Z, Said N, Amin S, et al. Galectins-3 and -7, but not galectin-1, play a role in reepithelialization of wounds [J]. Journal of Biological Chemistry, 2002, 277(44): 42299-42305.
[9] Maeda N, Kawada N. Stimulation of proliferation of hepatic stellate cells by galectin-1 and galectin-3 through different intracellular signaling pathways [J]. American Journal of Gastroenterology, 2003, 98(21): 18938-18944.
[10] Gordon S, Taylor P R. Monocyte and macrophage heterogeneity [J]. Nat Rev Immunol, 2005, 12(5): 953-964.
[11] Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization [J]. Trends Immunol, 2004, 25(12): 677-686.

[12] Feldman C. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia [J]. Journal of Laboratory & Clinical Medicine, 2004, 143(5): 269-283.
[13] Sibille Y, Reynolds H Y. Macrophages and polymorphonuclear neutrophils in lung defense and injury [J]. American Review of Respiratory Disease, 2012, 141(2): 471-501.
[14] Sato S, Ouellet N, Pelletier I, et al. Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia [J]. Journal of Immunology, 2002, 168(4):
1813-1822.
[15] Farnworth S L, Henderson N C, Mackinnon A C, et al. Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function [J]. American Journal of Pathology, 2008, 172(2): 395-405.
[16] Fermino M L, Polli C D, Toledo K A, et al. LPS-induced galectin-3 oligomerization results in enhancement of neutrophil activation [J]. PloS One, 2011, 6(10): e26004.
[17] Karlsson A, Christenson K, Matlak M, et al. Galectin-3 functions as an opsonin and enhances the macrophage clearance of apoptotic neutrophils [J]. Glycobiology, 2009, 19(1): 16-
20.
[18] Sano H, Hsu D K, Yu L, et al. Human galectin-3 is a novel chemoattractant for monocytes and macrophages [J]. Journal of Immunology, 2000, 165(4): 2156-2164.
[19] Yang R Y, Liu F T. Expression of galectin-3 modulates T-cell growth and apoptosis [J]. Proceedings of the National Academy of Sciences of the United States of America, 1996, 93(13): 6737-6742.
[20] Fukumori T, Takenaka Y, Yoshii T, et al. CD29 and CD7 mediate galectin-3-induced type ⅡT-cell apoptosis [J]. Cancer Research, 2004, 63(23): 8302-8311.
[21] Hsu D K, Yang R Y, Pan Z, et al. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses [J]. American Journal of Pathology, 2000, 156(3):
1073-1083.
[22] Galindo C L, Gutierrez C, Chopra A K. Potential involvement of galectin-3 and SNAP23 in Aeromonas hydrophila, cytotoxic enterotoxin-induced host cell apoptosis [J]. Microbial Pathogenesis, 2006, 40(2): 56-68.
[23] Herbert D R, Hölscher C, Mohrs M, et al. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and
immunopathology [J]. Immunity, 2004, 20(5): 455.
[24] Nair M G, Cochrane D W, Allen J E. Macrophages in chronic type 2 inflammation have a novel phenotype characterized by the abundant expression of Ym1 and Fizz1 that can be partly replicated in vitro [J]. Immunology Letters, 2003, 85(2): 173-180.
[25] Wynn T A. Fibrotic disease and the TH1/TH2 paradigm [J]. Nature Reviews Immunology, 2004, 4(8): 583-594.
[26] Zuberi R I, Hsu D K, Kalayci O, et al. Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma [J]. American Journal of Pathology, 2004, 165(6): 2045-2053.
[27] Dong S, Hughes R C. Macrophage surface glycoproteins binding to galectin-3 (Mac-2-antigen) [J]. Glycoconjugate Journal, 1997, 14(2): 267-274.

[28] Rintoul R C, Buttery R C, Mackinnon A C, et al. Cross-linking CD98 promotes integrinlike signaling and anchorage-independent growth [J]. Molecular Biology of the Cell, 2002, 13(8):
2841-2852.
[29] Henderson N C, Collis E A, Mackinnon A C, et al. CD98hc (SLC3A2) interaction with beta 1 integrins is required for transformation [J]. Journal of Biological Chemistry, 2004, 279(52):
54731-54741.
[30] Mackinnon A C, Farnworth S L, Hodkinson P S, et al. Regulation of alternative macrophage activation by galectin-3 [J]. Journal of Immunology, 2008, 180(4): 2650-2658.
[31] Partridge E A, Roy C L, Guglielmo G M D, et al. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis [J]. Science, 2004, 306(5693): 120-124.
[32] Henderson N C, Mackinnon A C, Farnworth S L, et al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis [J]. American Journal of Pathology, 2008, 172(2): 288-298.
[33] Vergaro G, Prud’homme M, Fazal L, et al. Inhibition of galectin-3 pathway prevents isoproterenol-induced left ventricular dysfunction and fibrosis in mice [J]. Journal of the American
College of Cardiology, 2015, 65(10): 606.
[34] Jeftic I, Jovicic N, Pantic J, et al. Galectin-3 ablation enhances liver steatosis, but attenuates inflammation and IL-33 dependent fibrosis in obesogenic mouse model of nonalcoholic
steatohepatitis [J]. Molecular Medicine, 2015, 21(1): 453-465.
[35] Fichtnerfeigl S, Strober W, Kawakami K, et al. IL-13 signaling through the IL-13a2 receptor is involved in induction of TGF-β1 production and fibrosis [J]. Nature Medicine, 2006,
12(1): 99-106.
[36] Liu T, Jin H, Ullenbruch M, et al. Regulation of found in inflammatory zone 1 expression in bleomycin-induced lung fibrosis: role of IL-4/IL-13 and mediation via STAT-6 [J]. Journal of
Immunology, 2004, 173(5): 3425-3431.
[37] Doucet C, Brouty-Boyé D, Pottin-Clemenceau C, et al. IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts [J].
International Immunology, 1998, 10(10): 1421-1433.
[38] Rishikof D C, Ricupero D A, Kuang P P, et al. Interleukin-4 regulates connective tissue growth factor expression in human lung fibroblasts [J]. Journal of Cellular Biochemistry, 2002,
85(3): 496-504.
[39] Puthenedam M, Wu F, Shetye A, et al. Matrilysin-1 (MMP7) cleaves galectin-3 and inhibits wound healing in intestinal epithelial cells [J]. Inflammatory Bowel Diseases, 2011, 17(1): 260-267.